MTOR and chronic myelogenous leukemia, BCR-ABL1 positive: The molecular pathways altered in CML, which include the JAK/STAT, NF-kB, WNT/β-catenin, PI3K/AKT/mTOR, Hedgehog and NOTCH pathways, are involved in LSCs maintenance and resistance to TKIs (7).